Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.

Identifieur interne : 00AA76 ( Ncbi/Checkpoint ); précédent : 00AA75; suivant : 00AA77

Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.

Auteurs : M V Pilepich ; S O Asbell ; G S Mulholland ; T. Pajak

Source :

RBID : pubmed:6483687

Descripteurs français

English descriptors

Abstract

One hundred thirty-six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75-06 and RTOG 77-06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25-30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.

PubMed: 6483687


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:6483687

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.</title>
<author>
<name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M V" last="Pilepich">M V Pilepich</name>
</author>
<author>
<name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S O" last="Asbell">S O Asbell</name>
</author>
<author>
<name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G S" last="Mulholland">G S Mulholland</name>
</author>
<author>
<name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T" last="Pajak">T. Pajak</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1984">1984</date>
<idno type="RBID">pubmed:6483687</idno>
<idno type="pmid">6483687</idno>
<idno type="wicri:Area/PubMed/Corpus">006A04</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006A04</idno>
<idno type="wicri:Area/PubMed/Curation">006A04</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006A04</idno>
<idno type="wicri:Area/PubMed/Checkpoint">006A04</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006A04</idno>
<idno type="wicri:Area/Ncbi/Merge">00AA76</idno>
<idno type="wicri:Area/Ncbi/Curation">00AA76</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">00AA76</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.</title>
<author>
<name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M V" last="Pilepich">M V Pilepich</name>
</author>
<author>
<name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S O" last="Asbell">S O Asbell</name>
</author>
<author>
<name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G S" last="Mulholland">G S Mulholland</name>
</author>
<author>
<name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T" last="Pajak">T. Pajak</name>
</author>
</analytic>
<series>
<title level="j">The Prostate</title>
<idno type="ISSN">0270-4137</idno>
<imprint>
<date when="1984" type="published">1984</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Biopsy</term>
<term>Carcinoma (pathology)</term>
<term>Carcinoma (radiotherapy)</term>
<term>Carcinoma (surgery)</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphatic Metastasis</term>
<term>Lymphedema (epidemiology)</term>
<term>Male</term>
<term>Neoplasm Staging</term>
<term>Prostatic Neoplasms (pathology)</term>
<term>Prostatic Neoplasms (radiotherapy)</term>
<term>Prostatic Neoplasms (surgery)</term>
<term>Radiotherapy Dosage</term>
<term>Random Allocation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Attribution aléatoire</term>
<term>Biopsie</term>
<term>Carcinomes ()</term>
<term>Carcinomes (anatomopathologie)</term>
<term>Carcinomes (radiothérapie)</term>
<term>Dosimétrie en radiothérapie</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Mâle</term>
<term>Métastase lymphatique</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de la prostate ()</term>
<term>Tumeurs de la prostate (anatomopathologie)</term>
<term>Tumeurs de la prostate (radiothérapie)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Carcinomes</term>
<term>Noeuds lymphatiques</term>
<term>Tumeurs de la prostate</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Carcinoma</term>
<term>Lymph Nodes</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Carcinoma</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Carcinomes</term>
<term>Tumeurs de la prostate</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Carcinoma</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Biopsy</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymphatic Metastasis</term>
<term>Male</term>
<term>Neoplasm Staging</term>
<term>Radiotherapy Dosage</term>
<term>Random Allocation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Attribution aléatoire</term>
<term>Biopsie</term>
<term>Carcinomes</term>
<term>Dosimétrie en radiothérapie</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mâle</term>
<term>Métastase lymphatique</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de la prostate</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">One hundred thirty-six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75-06 and RTOG 77-06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25-30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S O" last="Asbell">S O Asbell</name>
<name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G S" last="Mulholland">G S Mulholland</name>
<name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T" last="Pajak">T. Pajak</name>
<name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M V" last="Pilepich">M V Pilepich</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00AA76 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 00AA76 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:6483687
   |texte=   Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:6483687" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024